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Purpose: To assess whether tumor protein p53 gene (p53) polymorphisms are associated with primary open angle
glaucoma (POAG) in the Japanese population.
Methods: Four hundred and twenty-five Japanese patients with POAG, including normal tension glaucoma (NTG, n=213)
and high tension glaucoma (HTG, n=212) and 189 control subjects without glaucoma were analyzed for two p53
polymorphisms (rs1042522; a G→C substitution at codon 72 in exon 4 and rs59758982; a 16 base pair insertion in intron
3) using allele specific primer PCR and a pyrosequencing technique respectively. The genotypic and allelic frequencies
were compared between NTG or HTG patients and control subjects.
Results: No significant difference (NTG versus control, p=0.99, and HTG versus control, p=0.69, χ2 test) was observed
regarding the p53 genotype frequencies at codon 72 between the NTG (GG: 43.2%, GC: 44.6%, CC: 12.2%) or HTG
(GG: 40.1%, GC: 48.1%, CC: 11.8%) patients and the control subjects (GG: 43.9%, GC: 43.9%, CC: 12.2%). In addition,
there was no significant difference (NTG versus control, p=0.94; and HTG versus control, p=0.66, Fisher's exact test) in the
p53 allele frequencies at codon 72 between the NTG (G allele: 65.5%, C allele: 34.5%) or HTG (G allele: 64.2%, C allele:
35.8%) patients and the control subjects (G allele: 65.9%, C allele: 34.1%). No 16 base pair insertion in intron 3 was found
in this study.
Conclusion: p53 polymorphisms were not associated with POAG in the Japanese population. Further studies in the other
ethnic populations should therefore be performed to elucidate whether the p53 intron 3 insertion polymorphism is a genetic
risk factor for POAG, because the intron 3 insertion polymorphism occurs very rarely in the Japanese population.
Glaucoma is characterized by optic nerve atrophy with
an excavated optic nerve head and progressive visual field
loss,  and  it  can  potentially  result  in  bilateral  blindness.
Primary open-angle glaucoma (POAG) is the most common
form of glaucoma, and it is clinically classified into high
tension  glaucoma  (HTG),  in  which  elevated  intraocular
pressure  (IOP)  is  a  major  feature,  and  normal  tension
glaucoma (NTG), in which the IOPs are consistently within
the  statistically  normal  population  range.  Although  an
elevation of IOP is recognized as a major risk factor for optic
nerve  damage  in  POAG  [1],  POAG  is  a  complex  and
genetically  heterogeneous  disease  characterized  by  the
progressive apoptotic death of retinal ganglion cell (RGC),
and apoptosis-related genes seem to possibly be associated
with POAG, especially NTG.
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METHODS
Subjects: Japanese patients with POAG and control subjects
were recruited from ophthalmology practices in University of
Yamanashi Hospital, Enzan Municipal Hospital, Uenohara
City Hospital, and Oizumi Clinic in Yamanashi or Nagano
prefectures, Japan. A diagnosis of POAG was made when
open angles were detected on a gonioscopic examination and
typical glaucomatous cupping of the optic disc (thinning of
the optic disc rim and/or enlargement of the horizontal optic
disc cupping) with compatible visual field defects (nasal step
and/or partial arcuate visual field defect) was detected by
automated static perimetry (Humphrey Visual Field Analyzer
30-2, Humphrey Instruments, San Leandro, CA). In patients
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Tumor protein p53 (p53) is a nuclear phosphoprotein key
regulator of the cell cycle, and this protein is essential for cell
cycle arrest and the induction of apoptosis. Previous studies
have shown p53-associated apoptosis to be involved in POAG
pathogenesis [2], and p53 gene polymorphism may contribute
to the pathogenesis of POAG. In 2002, Lin et al. [3] first
reported the p53 codon 72 polymorphism to be associated with
POAG.  However,  the  association  between  such
polymorphisms  in  p53  and  POAG  remains  controversial
according to previous reports [3-6]. Further studies with a
larger number of cases and different ethnic populations are
thus called for to more fully elucidate the relationship between
p53  and  POAG.  In  this  study,  we  investigated  whether
polymorphisms in p53 were associated with POAG in the
Japanese population.with POAG, patients with HTG had evidence of at least one
previous IOP measurement that was more than 21 mm Hg
using  a  Goldmann  applanation  tomometer.  In  contrast,
patients with NTG showed an IOP of less than 21 mm Hg at
all tests. The patients were excluded if they had a history of
eye surgery, including laser treatment, before the diagnosis of
POAG. The control subjects consisted of Japanese who were
over 40 years of age, had IOP below 21 mm Hg, exhibited no
glaucomatous cupping of the optic disc (no thinning of disc
rim and cup-to-disc ratio less than 0.4) and had no family
history of glaucoma. All participants received comprehensive
ophthalmologic  examinations,  and  peripheral  blood  was
collected. The study protocol was approved by the Ethics
Committee of University of Yamanashi and informed consent
was  obtained  from  all  study  participants.  The  study  was
conducted in accordance with the Declaration of Helsinki.
Genomic DNA genotyping: Genomic DNA was purified with
a Flexi Gene® DNA Kit (Qiagen, Valencia, CA) and two p53
polymorphisms, a G→C substitution at codon 72 in exon 4
(rs1042522)  and  a  16  base  pair  insertion  in  intron  3
(rs59758982), were genotyped. An allele specific primer PCR
method was used for genotyping rs1042522, and the primers
shown in Table 1 were used for amplification. The 1st PCRs
were carried out in a total volume of 10 μl containing 10 ng
genomic DNA, 0.5 μM of each primer, 200 μM of each dNTP,
1.5 mM of MgCl2, and 0.5 U of Taq polymerase (GoTaq®
Flexi DNA polymerase; Promega Corporation, Madison, WI)
in a thermocycler (GeneAmp PCR System 9700; Applied
Biosystems Inc, Foster City, CA). Amplification was carried
out with an initial denaturation at 94 °C for 2 min, followed
by 35 cycles of denaturation at 94 °C for 20 s, annealing at 55
°C for 30 s, and extension at 72 °C for 30 s. A final extension
at 72 °C for 7 min completed the reactions. The 2nd PCRs
were carried out in a total volume of 20 μl containing 1st PCR
product, 0.2 μM of each primer, 200 μM of each dNTP, 1.5
mM of MgCl2, and 0.5 U of Taq polymerase (GoTaq® Flexi
DNA polymerase; Promega Corporation) in a thermocycler
(GeneAmp  PCR  System  9700;  Applied  Biosystems  Inc).
Amplifications for G and C allele genotyping were carried out
with an initial denaturation at 94 °C for 2 min, followed by 15
cycles of denaturation at 94 °C for 20 s and annealing at 65
°C and 62 °C for 30 s, respectively. The amplification products
were electrophoresed with 2% agarose gels, and genotypes
were  obtained.  To  perform  accurate  genotyping,  the
amplification products were accurately genotyped by direct
sequencing, and then were used as positive controls for this
method.  A  pyrosequencing  analysis  was  performed  for
genotyping  rs59758982  as  previously  described  [7].  The
primers shown in Table 1 were used for amplification and
sequencing.  The  5-end  biotinylation  for  the  PCR  reverse
primer was performed.
Statistical analysis: Data were analyzed using SAS statistical
software (version 9.1, SAS Institute Inc., Cary, NC). A χ2
analysis  of  the  Hardy-Weinberg  equilibrium  for  p53
genotypes  was  performed  for  the  patients  and  controls.
Genotypic and allelic frequency differences between POAG
patients and control subjects were estimated by the χ2 test and
Fisher’s  exact  test,  respectively.  A  value  of  p<0.05  was
considered to be statistically significant.
RESULTS
Four hundred and twenty-five Japanese patients with POAG
(213 patients with NTG and 212 patients with HTG) and 189
control subjects were enrolled in this study. The demographic
and clinical data in the patients with POAG and the control
subjects are shown in Table 2. The mean age at the time of
blood sampling was 63.4±14.3 years (standard deviation) in
patients  with  POAG  and  65.5±11.4  years  in  the  control
subjects. The mean age at the time of diagnosis was 57.4±13.3
and  54.4±15.3  years  in  patients  with  NTG  and  HTG,
respectively.  The  mean  of  maximum  known  IOP  was
23.5±8.2 in patients with POAG and 15.0±2.7 mmHg in the
control subjects.
The  genotype  and  allele  frequencies  of  p53
polymorphisms (rs1042522 and rs59758982) in patients with
POAG and the control subjects are shown in Table 3. The p53
TABLE 1. THE PRIMERS USED IN THIS STUDY.
Allele specific primer PCR method
Annealing
temperature
Product
    size
1st PCR
Forward Primer: 5’-TGGTCCTCTGACTGCTCTTT-3’ 55 °C 531 bp
Reverse Primer: 5’-AGGGTGTGATGGGATGGATAA-3’
2nd PCR for G allele genotyping
Forward Primer: 5’-ATGCCAGAGGCTGCTCGCCG-3’ 65 °C 398 bp
Reverse Primer: 5’-AGGGTGTGATGGGATGGATAA-3’
2nd PCR for C allele genotyping
Forward Primer: 5’-TGGTCCTCTGACTGCTCTTT-3’ 62 °C 172 bp
Reverse Primer: 5’-TGCTGGTGCAGGGGCCTCGG-3’
Pyrosequencing analysis
PCR forward primer: 5’-AATTCCATGGGACTGACTTTCTGC-3’ 60 °C 370 bp
PCR reverse primer: biotin labeled 5’-Bio-GGGAAGGGACAGAAGATGACAG-3’
Sequencing reverse primer: 5’-GGACAAGGGTTGGGC-3’
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equilibrium in patients with NTG and HTG and the control
subjects.  No  significant  difference  (NTG  versus  control,
p=0.99, and HTG versus control, p=0.69, χ2 test) was observed
regarding  the  p53  genotype  frequencies  at  codon  72
(rs1042522) between the NTG (GG: 43.2%, GC: 44.6%, CC:
12.2%) or HTG (GG: 40.1%, GC: 48.1%, CC: 11.8%) patients
and the control subjects (GG: 43.9%, GC: 43.9%, CC: 12.2%).
In addition, no significant difference (NTG versus control,
p=0.94; and HTG versus control, p=0.66, Fisher's exact test)
was  observed  in  the  p53  allele  frequencies  at  codon  72
between the NTG (G allele: 65.5%, C allele: 34.5%) or HTG
(G allele: 64.2%, C allele: 35.8%) patients and the control
subjects (G allele: 65.9%, C allele: 34.1%). No 16 base pair
insertion in intron 3 (rs59758982) was found.
DISCUSSION
In the current study, no significant differences were found
between the genotype and the allele frequencies of the p53
codon 72 polymorphism (rs1042522) among HTG or NTG
patients and control subjects. The statistical power was above
94%  to  detect  any  significant  difference  of  the  allele
frequencies  among  the  diagnostic  groups  at  α=0.05.  This
result  contrasts  with  that  of  Lin  et  al.  [3],  who  found  a
significantly higher prevalence of minor C allele at codon 72
G/C polymorphism caused the amino acid alteration from
arginine to proline in the 58 Chinese patients with POAG in
comparison to the 59 control subjects, although it is mostly
the same as those of the other previous studies [4-6]. There
are several possible explanations for this discrepancy. The
finding of Lin et al. [3] may thus have possibly been false
positive because of their small cohort size. The Arg72 variant
has been shown to induce apoptosis markedly better than does
the Pro72 variant [8]. Therefore, the Arg72 polymorphism
may  be  biologically  expected  to  confer  apoptotic
susceptibility.  However,  Lin  et  al.  [3]  concluded  that  the
Pro72, not the Arg72 variant, was a significant risk factor for
POAG. An alternative explanation may be a different case
definition of the patients in each study. A variety of genetic
factors  may  therefore  contribute  to  optic  neuropathy  in
POAG, and such factors may thus be classified to IOP and
non-IOP related genetic factors. Although it is not yet clear
how p53 polymorphisms might act, it is presumed that p53
contributes to optic neuropathy as a non-IOP related genetic
factor, because p53-associated apoptosis of RGC seems to be
involved in POAG pathogenesis [2]. Based on this point of
view, we classified the POAG patients as two groups (NTG
and HTG) by the IOP to evaluate the allele and genotype
frequencies,  because  the  non-IOP  related  genetic  factors
would  predominate  in  patients  with  NTG  while,  on  the
contrary,  the  high  IOP  related  genetic  factors  would
predominate in patients with HTG. On the other hand, their
study  did  not  classify  the  POAG  patients  by  the  IOP.
Alternatively, this different result between the Chinese and
Japanese  population  might  be  due  to  either  genetic
heterogeneity or the different genetic pathogenesis of POAG
between the two ethnic groups.
As  for  16  base  pair  insertion  polymorphism
(rs59758982) in intron 3, Ressiniotis et al. [5] reported a
significant difference in the p53 haplotype (rs1042522 and
rs59758982) distribution between 140 British patients with
POAG and 73 control subjects, and thus described that for
individuals  with  16  base  pair  insertion  polymorphism  an
Arg72 was significantly more common in the patients than the
controls. Acharya et al. [4] reported that the allele containing
the 16 base pair insertion was under represented (p=0.028) in
67 Indian patients with POAG compared to that in 112 control
subjects,  although  no  significant  (p=0.059)  genotype
frequency difference was found between them. The p53 intron
3  insertion  or  this  insertion  combined  with  an  Arg72
polymorphism may contribute to optic neuropathy for POAG.
Dimasi et al. [6] reported no significant difference in the same
haplotype distribution between 283 Australian HTG or 62
NTG patients and 178 control subjects. However, the cohort
size of NTG may not have been sufficient, as they mentioned
in their study [6]. Interestingly, no 16 base pair insertion in
intron  3  was  found  in  this  study.  Hiyama  et  al.  [9]  also
TABLE 2. DEMOGRAPHIC AND CLINICAL FEATURES IN CONTROL SUBJECTS AND PATIENTS WITH POAG.
Demographic and clinical features
Control
(n = 189)
POAG
NTG
(n = 213)
HTG
(n = 212)
Age at blood sampling (years) 65.5±11.4 63.9±13.7 62.9±14.8
Age at diagnosis (years) - 57.4±13.3 54.4±15.3
Male Gender, n (%) 70 (37.0) 91 (42.7) 129 (60.8)
Maximum IOP (mmHg) 15.0±2.7 18.5±1.9 28.5±9.0
Refractive error (diopter) -0.4±2.2 -2.0±3.4 -2.1±3.0
Familial history of glaucoma, n (%) 0 (0) 48 (22.5) 62 (29.2)
POAG: primary open angle glaucoma, NTG: normal tension glaucoma, HTG: high tension glaucoma, IOP: intraocular pressure.
Continuous variables are expressed as mean±standard deviation.
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Japanese population. The reason for dissimilar findings may
reflect the ethnic difference in the p53 intron 3 insertion allele
frequencies. At least, the POAG patients associated with the
intron 3 insertion or this insertion combined with an Arg72
polymorphism are very few in the Japanese population, even
though  these  polymorphisms  would  contribute  to  optic
neuropathy in POAG.
In conclusion, p53 polymorphisms were not associated
with POAG in the Japanese population. Further studies in
other ethnic populations with large numbers of patients and
well-defined diagnostic criteria should thus be performed to
elucidate whether the p53 intron 3 insertion or this insertion
combined with a codon 72 polymorphism is a genetic risk
factor  for  POAG,  especially  NTG,  because  the  intron  3
insertion  polymorphism  seems  to  be  a  rare  event  in  the
Japanese population.
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